This study, co-authored by Can-Change member Dr. Michael Vallis, investigated whether a standardized, telephone-based weight loss lifestyle intervention in the adjuvant setting would impact BC outcomes.
Étiquette : breast cancer
The LISA Trial
Obesity is associated with poor outcomes in women with operable breast cancer. Lifestyle interventions (LIs) that help women reduce their weight may improve outcomes. A telephone-based LI led to significant weight loss that was still evident at 24 months, without adverse effects on QOL, hospitalizations, or medical events. Can-Change member Dr. Michael Vallis contributed to this article.